MX2009003484A - Azitromicina para el tratamiento de acne nodular. - Google Patents

Azitromicina para el tratamiento de acne nodular.

Info

Publication number
MX2009003484A
MX2009003484A MX2009003484A MX2009003484A MX2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A MX 2009003484 A MX2009003484 A MX 2009003484A
Authority
MX
Mexico
Prior art keywords
treatment
azithromycin
nodular acne
acne
nodular
Prior art date
Application number
MX2009003484A
Other languages
English (en)
Inventor
David Wade Osborne
Gordon Jay Dow
Bhaskar Chaudhuri
Barry Calvarese
Original Assignee
Dow Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences filed Critical Dow Pharmaceutical Sciences
Publication of MX2009003484A publication Critical patent/MX2009003484A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)

Abstract

La azitromicina, administrada sistémicamente, es un tratamiento efectivo para nódulos asociados con acné vulgar.
MX2009003484A 2006-10-03 2007-09-24 Azitromicina para el tratamiento de acne nodular. MX2009003484A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84906506P 2006-10-03 2006-10-03
US11/635,127 US7704959B2 (en) 2006-10-03 2006-12-06 Azithromycin for the treatment of nodular acne
PCT/US2007/020583 WO2008042139A2 (en) 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne

Publications (1)

Publication Number Publication Date
MX2009003484A true MX2009003484A (es) 2009-10-26

Family

ID=39261797

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003484A MX2009003484A (es) 2006-10-03 2007-09-24 Azitromicina para el tratamiento de acne nodular.

Country Status (19)

Country Link
US (2) US7704959B2 (es)
EP (2) EP2086552B1 (es)
JP (1) JP2010505827A (es)
KR (1) KR20090064592A (es)
CN (2) CN101534837B (es)
AT (1) ATE533496T1 (es)
AU (1) AU2007302663B2 (es)
BR (1) BRPI0719535A2 (es)
CA (1) CA2664673A1 (es)
CY (1) CY1112650T1 (es)
DK (1) DK2086552T3 (es)
ES (2) ES2377470T3 (es)
HK (1) HK1130667A1 (es)
MX (1) MX2009003484A (es)
PL (2) PL2086552T3 (es)
PT (1) PT2086552E (es)
RU (1) RU2009116629A (es)
SI (1) SI2086552T1 (es)
WO (1) WO2008042139A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法
BR112020000968A2 (pt) * 2017-07-21 2020-07-14 Almirall, Llc tratamento de lesões não inflamatórias

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474758A (en) 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4474766A (en) 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
MX12213A (es) 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
FR2710841B1 (fr) 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
GB9723669D0 (en) 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
CA2719162C (en) * 2001-04-05 2014-12-23 Galderma Pharma S.A. Methods of treating acne
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US9035741B2 (en) * 2003-06-27 2015-05-19 Stryker Corporation Foot-operated control console for wirelessly controlling medical devices

Also Published As

Publication number Publication date
JP2010505827A (ja) 2010-02-25
EP2086552A2 (en) 2009-08-12
AU2007302663B2 (en) 2012-07-12
RU2009116629A (ru) 2010-11-10
EP2420240B1 (en) 2016-05-11
CN102614210A (zh) 2012-08-01
WO2008042139A2 (en) 2008-04-10
US20080081790A1 (en) 2008-04-03
CY1112650T1 (el) 2016-02-10
DK2086552T3 (da) 2012-01-09
KR20090064592A (ko) 2009-06-19
US7704959B2 (en) 2010-04-27
ATE533496T1 (de) 2011-12-15
WO2008042139A3 (en) 2008-10-16
EP2086552A4 (en) 2009-11-04
HK1130667A1 (en) 2010-01-08
ES2377470T3 (es) 2012-03-27
PL2420240T3 (pl) 2016-10-31
CN101534837B (zh) 2012-04-04
CN101534837A (zh) 2009-09-16
AU2007302663A1 (en) 2008-04-10
ES2574677T3 (es) 2016-06-21
EP2086552B1 (en) 2011-11-16
PT2086552E (pt) 2011-12-19
US20100216732A1 (en) 2010-08-26
BRPI0719535A2 (pt) 2014-01-14
CA2664673A1 (en) 2008-04-10
EP2420240A1 (en) 2012-02-22
SI2086552T1 (sl) 2012-01-31
PL2086552T3 (pl) 2012-03-30

Similar Documents

Publication Publication Date Title
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TW200738725A (en) Unsaturated mTOR inhibitors
MX2007000611A (es) Tratamiento de la piel con luz y un agente benefico para mitigar el acne.
MX2009006481A (es) Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona.
WO2007127263A3 (en) Therapeutic uses of urolithins
MX364102B (es) Medicamentos para usarse en el tratamiento de la encefalopatía hepática.
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
TNSN08400A1 (en) Organic compounds and their uses
MY150493A (en) Quinazoline derivatives
WO2008070743A3 (en) Methods of increasing cancer sensitivity to chemotherapeutic agents using chimeric isf35
MX2009003484A (es) Azitromicina para el tratamiento de acne nodular.
MY148651A (en) Antitumoral compounds
WO2009101199A3 (en) Treatment of acne vulgaris; rosacea and rhinophym
NO20092496L (no) Ny terapeutisk anvendelse for behandling av leukemi
MX2009013214A (es) Macrociclos y sus usos.
WO2010149688A3 (en) Antitumoral compounds
MY166063A (en) Intravenous antiviral treatments
EA200802136A1 (ru) Лечение меланомы
MX2010002046A (es) Tratamiento de cancer de pulmon.
MX2009009777A (es) Administracion intravesical de apaziquone despues de reseccion transuretral para tratamiento de cancer.
UA27723U (en) 7-? -hydroxy- ? -(2',4'-dichlorophenoxy)-propyl-8-n-(n'-?-hydroxyethyl)-piperazino-3- methylxanthine revealing hypocholesteremic action
WO2007127908A3 (en) Dihydrobenzoquinone compounds
TW200743134A (en) Exhausting apparatus
CA117081S (en) Handleset grip

Legal Events

Date Code Title Description
FG Grant or registration